Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 22.67B P/E 62.66 EPS this Y -4.50% Ern Qtrly Grth 108.40%
Income 438M Forward P/E 14.65 EPS next Y 22.00% 50D Avg Chg -2.00%
Sales 3.64B PEG 5.01 EPS past 5Y 40.13% 200D Avg Chg -2.00%
Dividend N/A Price/Book 4.44 EPS next 5Y 5.00% 52W High Chg -13.00%
Recommedations 3.00 Quick Ratio 3.49 Shares Outstanding 229M 52W Low Chg 71.00%
Insider Own 1.18% ROA 4.44% Shares Float 211.06M Beta 1.01
Inst Own 100.85% ROE 8.54% Shares Shorted/Prior 7.10M/7.86M Price 99.01
Gross Margin 77.36% Profit Margin 12.02% Avg. Volume 2,258,041 Target Price 116.50
Oper. Margin 17.68% Earnings Date - Volume 1,096,481 Change -0.68%
About Horizon Therapeutics Public Lim

Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; Arrowhead Pharmaceuticals, Inc.; Q32 Bio Inc.; and Xeris Biopharma Holdings, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.

Horizon Therapeutics Public Lim News
10/06/23 Rule 17(e) Announcement - Horizon Therapeutics plc
10/03/23 Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
10/02/23 Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
09/29/23 New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes
09/26/23 Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry
09/19/23 FTC chair targets deals that have fallen in agency's 'blind spots'
09/19/23 Healthcare: FTC Chair Lina Khan to crack down on 'below radar' deals
09/19/23 Horizon Therapeutics plc Ranks Number One on the Fortune Best Workplaces in Biopharma 2023 List
09/13/23 Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata
09/06/23 Horizon Therapeutics plc ("Horizon") Rule 2.12 Announcement
09/05/23 Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement
09/01/23 AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
08/31/23 Is This the Green Light Biotech Stocks Have Been Waiting For?
08/28/23 FTC suspends challenge to Amgen-Horizon Therapeutics deal
08/23/23 Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
08/09/23 Horizon Therapeutics plc - Rule 2.12 Announcement
08/08/23 Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results
08/04/23 Amgen raises full-year earnings and revenue outlook
07/27/23 Horizon Therapeutics plc Announces 2023 #RAREis Global Advocate Grant Recipients
07/21/23 Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Daxdilimab for the Treatment of Systemic Lupus Erythematosus (SLE) Did Not Meet Primary Endpoint
HZNP Chatroom

User Image Ycapital Posted - 2 months ago

$ATVI $HZNP $VMW

User Image Oppie001 Posted - 2 months ago

$IOVA Yep! Seen this movie before $HZNP. Pop heavy

User Image JthanP Posted - 2 months ago

$IOVA this stock was an oldie but goodie...owned this 2 years ago, and let me say, this reminds me of another $HZNP I had. They may try to shake the apples from the tree....but just have conviction. Congrats to the Bulls, and GLTA!

User Image hashtagzee Posted - 2 months ago

$AUPH $HZNP Remember this PR by a former Aurinia BOD member and then CEO of Horizon Tim Walbert? https://www.investors.com/news/technology/hznp-stock-rockets-as-it-considers-potential-bids-from-three-big-pharma-stalwarts/ At this stage of the game, for a single asset company you either have offers or you have none. If they really had any genuine interest, they would go this route and generate some bidding action. My guess is they’ve got nothing and if that is the case, PG must be sacked for his dismal GIA performance thus far.

User Image BullMarketStocks Posted - 3 months ago

@howhardgerrard87 I bought into both $ardx and $calt Jan of last year after $hznp got bought out, also deployed that cash into $agio as another smaller bio bet.

User Image bdubs84 Posted - 3 months ago

$CYTK the betaville rumor on Amgen is garbage…they are literally the worst pump and dump shop out there. Amgen closed $HZNP in October and has nowhere near the balance sheet to support a $10B+ acquisition after shelling out $28B for $HZNP. Most likely suitor based on balance sheet alone would be $JNJ as they have the cash to do a deal this big and have already been mentioned as one of the three likely bidders per WSJ.

User Image Coastalcool Posted - 3 months ago

$AMAM $HZNP $TCBP $TPST

User Image FBP Posted - 3 months ago

$BCRX solid prelim ER but bigger q is wtf is the market going to valuations? Cuz it seems very GIA atm and even at that pretty cheap. Could see this be a horizon $HZNP some day

User Image Coastalcool Posted - 3 months ago

$TCBP A Look at recent history of some battered bios such as $AMAM , $TPST & others will tell you that only the ones who persevered blocked the noise took it home. Some great names such as $HZNP were down to sub $ but thrived to become a multi Billion$ bios. The game is on for me & others. Kuddos to them if they took their winning hands & left. As for the rest of us its just noise right now.

User Image muldoon92 Posted - 4 months ago

$AMGN one of my top plays for 2024. Look at the monthly bars converging. Retest of all time highs likely coming soon with: *bullish optimism surrounding biotech with $XBI turnaround *JPM24 usually yielding more M&A moves *obesity data readouts *hopefully positive updates on $HZNP integration *3% dividend yield to boot What’s not to love here? Wish we could get a more attractive entry price but will likely acquire 25-50% of desired size initially and rest on any pullbacks in new year…

User Image Quantumup Posted - 4 months ago

BMO⬆️ $AMGN OP/$326: A budding oral/inj pipe gives invs the opp2play obesity w/out the same premium as peers like $LLY (still🩷); closure of $HZNP deal takes step towards replacing rev lost2base biz erosion; a rich cat path into '24 for its pipe could drive add'l multi expansion.

User Image kimberlyanoerrth Posted - 4 months ago

$HZNP Who thinks this is real?! I saw is on another board yesterday and it seems scary! https://www.youtube.com/watch?v=ds-TrAnK2uQ

User Image Coastalcool Posted - 11/27/23

@IDEXTOMOON But I am alive &well. Every t10% drop, I get 10% energized & focused. I will be your night mare. I bought $HZNP 15 years ago was still in it when $AMGN bought it at $127/share.

User Image digitalcori Posted - 5 months ago

📈💼 Tudor Investment Corp's buys surge! From biotech to tech giants, Jones' moves reveal confidence! Explore the $1.43B boost & the new additions reshaping the portfolio! 💹🚀 #InvestmentMoves #TudorInvestment Q3 2023 portfolio, worth $9.73 Billion and containing 2226 stocks Top holding: $ATVI, $SGEN, $SPLK, $HZNP, and $SPY https://tickertracker.io/articles/pyo82q68v0-paul-tudor-jones-reveals-9-73-billion-portfolio-holdings-for-q3-2023-insights-into-investment-strategy-and-decision-making

User Image TrendyChart Posted - 10/26/23

Upcoming Earnings Report: $HZNP Horizon Therapeutics will be reporting on 11/06/2023 at 7:00AM | Will earnings surpass or fall short of projections?

User Image Coastalcool Posted - 6 months ago

$QNRX is proudly joining the list of Rare Genetic Diseases $SRPT , $HZNP etc. For the first time the Kids of NS could be kids. QRX003 as a srrine protesse inhibitor can work on other Rare/Genetic Skin Diseases as off label.

User Image cctranscripts Posted - 6 months ago

Securities registration termination [Section 12(g)] https://www.conferencecalltranscripts.org/summary/?id=12618142 $HZNP

User Image ChartMill Posted - 6 months ago

New 52 week highs for $HZNP, $SUZ, $MPLX, $NATI and $FAST https://www.chartmill.com/stock/stock-screener?f=p_pg10,v1_50b500,s_nh,exch_us&v=3&utm_source=New_52_week_high_today&utm_medium=stocktwits&utm_campaign=screen

User Image WOLFSTREET Posted - 6 months ago

$HZNP Wow, this activist oldie really gets paid by the market to fund his stuff. He picked this up in mass when the markets brought the price down ??? around Q3-Q4 2022. By the time word got out, it recovered FAST! I think Soros himself may be the ultimate COMPASS.

User Image UltraAlgo Posted - 6 months ago

$HZNP Awaiting Short Signal based off 5 signals, based on the 15 minute chart. Chart by 🚀 UltraAlgo https://i.redd.it/528jqinnu7tb1.png

User Image tickeron Posted - 6 months ago

Maybe this is a good chance to make a profit? $HZNP in +0.07% Uptrend, rising for three consecutive days on October 5, 2023. View odds for this and other indicators: https://srnk.us/go/4885731

User Image Coastalcool Posted - 6 months ago

$QNRX This company is the next $HZNP , just aquired by $AMGN for $129/share.See the similarities * They both address the umet needs of Rare/Genetic Orphan Diseases. * Both were granted IND for their assets. * Both are extremely vital to their perspective disease group. * They both have the Mega Pricing Power. $HZNP has raised its prices about 16x in the last 14 years. where $QNRX superceed $HZNP is the followings: * QRX04: going to Clincal in q1, 2024 for Epidermolysis Bolusa ( Rare Genetic Disease) * * QRX07: inline to go Clinical trial in 2024 for Scleroderma, a divestating & killer diease, Rare& Genetic disease. *** Off label use of QRX03 for all other Rare & Genetic diseases.

User Image stockilluminati Posted - 6 months ago

$HZNP https://clinicaltrials.gov/study/NCT05831098 - trial update posted here!

User Image TeresaTrades Posted - 6 months ago

Largest CALL OI decreases $HZNP $SBSW $EQT $TEVA $FYBR http://staygreen.blackboxstocks.com/SH4G🎉

User Image TrendyChart Posted - 6 months ago

Upcoming Earnings Report: $HZNP Horizon Therapeutics will be reporting on 11/01/2023 at 7:00AM | Are you inclined towards a positive or negative earnings outlook?

User Image Berkshireannhathaway Posted - 6 months ago

$HZNP

User Image STOCK_DAILY_NEWS Posted - 6 months ago

https://www.linkedin.com/feed/update/urn:li:activity:7117117041311907842 #PressRelease - #GoldmanSmallCap Research Publishes New Research Report on @TheRegenBio $RGBP @RegenBioPharm @EmergingGrowthC @GoldmanSmallCap @jctb1 @PWExchangeINC $ABBV $VRTX $HZNP @Biotech2k1 @BioStocks @crypto_biotech @GoldmanSachs

User Image tickeron Posted - 6 months ago

How does this affect your portfolio? $HZNP The volume increased for two consecutive days, resulting in a record-breaking daily growth of 379% of the 65-Day Volume Moving Average. View odds of downtrend. https://srnk.us/go/4881354

User Image stockilluminati Posted - 6 months ago

$HZNP https://www.stockilluminati.com/hznp/filings.php - Horizon Therapeutics Public Limited Company - Ordinary Shares files form 4 today, check out the details.

User Image cctranscripts Posted - 6 months ago

Horizon Pharma's EVP and Chief Medical Officer just disposed of 234,759 shares https://www.conferencecalltranscripts.org/summary/?id=12599804 $HZNP

Analyst Ratings
BMO Capital Market Perform Dec 13, 22
Guggenheim Neutral Dec 13, 22
SVB Leerink Market Perform Dec 13, 22
Wells Fargo Equal-Weight Dec 13, 22
Stifel Hold Dec 12, 22
Piper Sandler Overweight Dec 7, 22
SVB Leerink Outperform Nov 3, 22
HC Wainwright & Co. Neutral Nov 1, 22
Piper Sandler Overweight Oct 25, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
SANTINI GINO Director Director Oct 02 Option 15.23 23,092 351,691 100,959 10/02/23
Watkins Thomas Director Director Sep 29 Option 14.04 81,323 1,141,775 110,447 10/02/23
Shannon James Samuel Director Director Sep 29 Option 12.19 11,850 144,452 33,156 10/02/23
GREY MICHAEL G Director Director Sep 28 Option 15.96 20,000 319,200 39,361 09/28/23
Himawan Jeff Director Director Sep 26 Option 13.87 32,161 446,073 44,546 09/27/23
SANTINI GINO Director Director Sep 22 Option 15.96 20,000 319,200 77,867 09/25/23
Pasternak Andy EVP, Chief Strategy.. EVP, Chief Strategy Officer Jan 17 Sell 113.0275 27,129 3,066,323 56,338 01/18/23
Cox Aaron EVP, Chief Financial.. EVP, Chief Financial Officer Jan 13 Sell 113.1694 36,148 4,090,847 277 01/17/23
SHERMAN JEFFREY W EVP and Chief Medica.. EVP and Chief Medical Officer Jan 04 Sell 113.29 5,187 587,635 49,314 01/06/23
Clayton Sean M. EVP, General Counsel EVP, General Counsel Aug 04 Buy 66.67 745 49,669 745 08/08/22
Pasternak Andy EVP and Chief Busine.. EVP and Chief Business Officer Jul 29 Sell 82.95 4,850 402,308 34,047 07/29/22
Thompson Elizabeth H.Z. EVP, Research & Deve.. EVP, Research & Development Jul 19 Sell 85.02 6,007 510,715 6,969 07/20/22
Thompson Elizabeth H.Z. EVP, Research & Deve.. EVP, Research & Development Jul 07 Sell 85.01 82 6,971 12,976 07/11/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Jun 03 Option 22.14 25,000 553,500 460,826 06/03/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Jun 03 Sell 92.41 25,000 2,310,250 435,826 06/03/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO May 20 Option 22.14 25,000 553,500 485,549 05/20/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO May 20 Sell 90 25,000 2,250,000 460,549 05/20/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO May 06 Option 22.14 7,400 163,836 467,949 05/10/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO May 06 Sell 90.72 7,400 671,328 460,549 05/10/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Apr 22 Option 22.14 25,000 553,500 510,549 04/22/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Apr 22 Sell 107.61 25,000 2,690,250 485,549 04/22/22
Hoelscher Paul W. EVP, CFO EVP, CFO Apr 20 Sell 114.77 50,000 5,738,500 1,049 04/22/22
Hoelscher Paul W. EVP, CFO EVP, CFO Apr 20 Option 22.14 50,000 1,107,000 51,049 04/22/22
DesJardin Michael A. EVP, Technical Opera.. EVP, Technical Operations Apr 12 Sell 113.08 20,214 2,285,799 82,346 04/14/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Mar 25 Sell 109.37 25,000 2,734,250 535,549 03/25/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Mar 25 Option 22.14 25,000 553,500 560,549 03/25/22
Hoelscher Paul W. EVP, CFO EVP, CFO Mar 23 Option 15.96 26,090 416,396 27,139 03/25/22
Hoelscher Paul W. EVP, CFO EVP, CFO Mar 23 Sell 110 39,933 4,392,630 158,383 03/25/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Mar 11 Option 22.14 25,000 553,500 560,549 03/11/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Mar 11 Sell 101.08 25,000 2,527,000 535,549 03/11/22
Pasternak Andy EVP and Chief Busine.. EVP and Chief Business Officer Feb 18 Sell 94.82 1,313 124,499 39,659 02/18/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Jan 28 Option 22.14 25,000 553,500 710,549 01/31/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Jan 28 Sell 91.33 125,000 11,416,250 585,549 01/31/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Jan 14 Option 22.14 25,000 553,500 699,222 01/14/22
Walbert Timothy P Chairman, President.. Chairman, President and CEO Jan 14 Sell 90.02 25,000 2,250,500 674,222 01/14/22
Pasternak Andy EVP and Chief Busine.. EVP and Chief Business Officer Jan 04 Sell 98.93 7,987 790,154 40,972 01/06/22
Hoelscher Paul W. EVP, CFO EVP, CFO Dec 28 Sell 110 8,575 943,250 1,049 12/30/21
Hoelscher Paul W. EVP, CFO EVP, CFO Dec 28 Option 15.96 8,575 136,857 9,624 12/30/21
Walbert Timothy P Chairman, President.. Chairman, President and CEO Nov 30 Sell 102.55 50,000 5,127,500 504,482 12/01/21
Walbert Timothy P Chairman, President.. Chairman, President and CEO Apr 30 Sell 94.65 25,000 2,366,250 899,838 04/30/21
MOZE BARRY EVP, Chief Admin. Of.. EVP, Chief Admin. Officer Apr 13 Sell 89.53 65,613 5,874,332 105,665 04/13/21
GREY MICHAEL G Director Director Apr 13 Option 2.37 15,000 35,550 15,000 04/13/21
CURTIS GEOFFREY M. EVP, Corporate Affai.. EVP, Corporate Affairs, CCO Apr 02 Option 28.33 37,000 1,048,210 123,414 04/02/21
CURTIS GEOFFREY M. EVP, Corporate Affai.. EVP, Corporate Affairs, CCO Apr 02 Sell 93.51 70,739 6,614,804 52,675 04/02/21
Karnani Vikram EVP & President, Int.. EVP & President, International Jan 22 Option 0 4,904 116,333 01/22/21
Karnani Vikram EVP & President, Int.. EVP & President, International Jan 22 Sell 76.81 2,731 209,768 111,429 01/22/21
Konstantinovsky Irina EVP, Chief Human Res.. EVP, Chief Human Resources Off Jan 22 Option 0 3,999 90,498 01/22/21
Konstantinovsky Irina EVP, Chief Human Res.. EVP, Chief Human Resources Off Jan 22 Sell 76.81 2,226 170,979 86,500 01/22/21
Walbert Timothy P Chairman, President.. Chairman, President and CEO Jan 22 Option 0 22,905 14,563 01/22/21
Walbert Timothy P Chairman, President.. Chairman, President and CEO Jan 22 Sell 76.58 11,323 867,115 946,559 01/22/21